BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wilbaux M, Fuchs A, Samardzic J, Rodieux F, Csajka C, Allegaert K, van den Anker JN, Pfister M. Pharmacometric Approaches to Personalize Use of Primarily Renally Eliminated Antibiotics in Preterm and Term Neonates. J Clin Pharmacol 2016;56:909-35. [PMID: 26766774 DOI: 10.1002/jcph.705] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Koch G, Schropp J, Pfister M. Facilitate Treatment Adjustment After Overdosing: Another Step Toward 21st-Century Medicine. The Journal of Clinical Pharmacology 2017;57:704-11. [DOI: 10.1002/jcph.852] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
2 Kontou A, Sarafidis K, Roilides E. Antimicrobial dosing in neonates. Expert Rev Clin Pharmacol 2017;10:239-42. [PMID: 28067058 DOI: 10.1080/17512433.2017.1279968] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
3 Keij FM, Kornelisse RF, Hartwig NG, Reiss IKM, Allegaert K, Tramper-Stranders GA. Oral antibiotics for neonatal infections: a systematic review and meta-analysis. J Antimicrob Chemother 2019;74:3150-61. [PMID: 31236572 DOI: 10.1093/jac/dkz252] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
4 Sasano H, Aoki K, Arakawa R, Hanada K. Population Pharmacokinetic Analysis and Dose Regimen Optimization in Japanese Infants with an Extremely Low Birth Weight. Antimicrob Agents Chemother 2021;65:e02523-20. [PMID: 33318009 DOI: 10.1128/AAC.02523-20] [Reference Citation Analysis]
5 Allegaert K. Rational Use of Medicines in Neonates: Current Observations, Areas for Research and Perspectives. Healthcare (Basel) 2018;6:E115. [PMID: 30223533 DOI: 10.3390/healthcare6030115] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Brussee JM, Calvier EA, Krekels EH, Välitalo PA, Tibboel D, Allegaert K, Knibbe CA. Children in clinical trials: towards evidence-based pediatric pharmacotherapy using pharmacokinetic-pharmacodynamic modeling. Expert Rev Clin Pharmacol 2016;9:1235-44. [PMID: 27269200 DOI: 10.1080/17512433.2016.1198256] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
7 Huang X, Yu Z, Bu S, Lin Z, Hao X, He W, Yu P, Wang Z, Gao F, Zhang J, Chen J. An Ensemble Model for Prediction of Vancomycin Trough Concentrations in Pediatric Patients. Drug Des Devel Ther 2021;15:1549-59. [PMID: 33883878 DOI: 10.2147/DDDT.S299037] [Reference Citation Analysis]
8 Zhang Y, Mehta N, Muhari-Stark E, Burckart GJ, van den Anker J, Wang J. Pediatric Renal Ontogeny and Applications in Drug Development. J Clin Pharmacol 2019;59 Suppl 1:S9-S20. [PMID: 31502684 DOI: 10.1002/jcph.1490] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
9 Leroux S, Biran V, van den Anker J, Gotta V, Zhao W, Zhang D, Jacqz-Aigrain E, Pfister M. Serum Creatinine and Serum Cystatin C are Both Relevant Renal Markers to Estimate Vancomycin Clearance in Critically Ill Neonates. Front Pharmacol 2021;12:634686. [PMID: 33967770 DOI: 10.3389/fphar.2021.634686] [Reference Citation Analysis]
10 van Donge T, Pfister M, Bielicki J, Csajka C, Rodieux F, van den Anker J, Fuchs A. Quantitative Analysis of Gentamicin Exposure in Neonates and Infants Calls into Question Its Current Dosing Recommendations. Antimicrob Agents Chemother 2018;62:e02004-17. [PMID: 29358294 DOI: 10.1128/AAC.02004-17] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
11 van Donge T, Welzel T, Atkinson A, van den Anker J, Pfister M. Age-Dependent Changes of Kidney Injury Biomarkers in Pediatrics. J Clin Pharmacol 2019;59 Suppl 1:S21-32. [PMID: 31502686 DOI: 10.1002/jcph.1487] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
12 Allegaert K, Simons S, Van Den Anker J. Research on medication use in the neonatal intensive care unit. Expert Rev Clin Pharmacol 2019;12:343-53. [PMID: 30741041 DOI: 10.1080/17512433.2019.1580569] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
13 Tseng SH, Lim CP, Chen Q, Tang CC, Kong ST, Ho PC. Evaluating the Relationship between Vancomycin Trough Concentration and 24-Hour Area under the Concentration-Time Curve in Neonates. Antimicrob Agents Chemother 2018;62:e01647-17. [PMID: 29358290 DOI: 10.1128/AAC.01647-17] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
14 Wu YE, Wang YK, Tang BH, Dong L, Li X, Zhang W, Li DF, Tian LY, van den Anker J, You DP, Zhao W. Population Pharmacokinetics and Dosing Optimization of Amoxicillin in Chinese Infants. J Clin Pharmacol 2021;61:538-46. [PMID: 32996155 DOI: 10.1002/jcph.1752] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Momper JD, Yang J, Gockenbach M, Vaida F, Nigam SK. Dynamics of Organic Anion Transporter-Mediated Tubular Secretion during Postnatal Human Kidney Development and Maturation. Clin J Am Soc Nephrol 2019;14:540-8. [PMID: 30885911 DOI: 10.2215/CJN.10350818] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
16 Wang J, van den Anker JN, Burckart GJ. Progress in Drug Development-Pediatric Dose Selection: Workshop Summary. J Clin Pharmacol 2021;61 Suppl 1:S13-21. [PMID: 34185909 DOI: 10.1002/jcph.1828] [Reference Citation Analysis]
17 Cremers S, Guha N, Shine B. Therapeutic drug monitoring in the era of precision medicine: opportunities! Br J Clin Pharmacol 2016;82:900-2. [PMID: 27612297 DOI: 10.1111/bcp.13047] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
18 Job KM, Gamalo M, Ward RM. Pediatric Age Groups and Approach to Studies. Ther Innov Regul Sci 2019;53:584-9. [PMID: 31311309 DOI: 10.1177/2168479019856572] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
19 van den Anker J, Allegaert K. Considerations for Drug Dosing in Premature Infants. J Clin Pharmacol 2021;61 Suppl 1:S141-51. [PMID: 34185893 DOI: 10.1002/jcph.1884] [Reference Citation Analysis]
20 Leopoldino RD, Santos MT, Costa TX, Martins RR, Oliveira AG. Drug related problems in the neonatal intensive care unit: incidence, characterization and clinical relevance. BMC Pediatr 2019;19:134. [PMID: 31027487 DOI: 10.1186/s12887-019-1499-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
21 Wang J, Kumar SS, Sherwin CM, Ward R, Baer G, Burckart GJ, Wang Y, Yao LP. Renal Clearance in Newborns and Infants: Predictive Performance of Population-Based Modeling for Drug Development. Clin Pharmacol Ther 2019;105:1462-70. [PMID: 30565653 DOI: 10.1002/cpt.1332] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
22 Smits A, Kulo A, van den Anker J, Allegaert K. The amikacin research program: a stepwise approach to validate dosing regimens in neonates. Expert Opin Drug Metab Toxicol 2017;13:157-66. [PMID: 27623706 DOI: 10.1080/17425255.2017.1234606] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
23 Smits A, De Cock PAJG. Antibiotic PK/PD research in critically ill neonates and children: how do we proceed? International Journal of Pharmacokinetics 2018;3:1-3. [DOI: 10.4155/ipk-2017-0019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
24 Wang K, Jiang K, Wei X, Li Y, Wang T, Song Y. Physiologically Based Pharmacokinetic Models Are Effective Support for Pediatric Drug Development. AAPS PharmSciTech 2021;22:208. [PMID: 34312742 DOI: 10.1208/s12249-021-02076-w] [Reference Citation Analysis]
25 van den Anker J, Reed MD, Allegaert K, Kearns GL. Developmental Changes in Pharmacokinetics and Pharmacodynamics. The Journal of Clinical Pharmacology 2018;58:S10-25. [DOI: 10.1002/jcph.1284] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 16.0] [Reference Citation Analysis]
26 Wang H, Sherwin C, Gobburu JVS, Ivaturi V. Population Pharmacokinetic Modeling of Gentamicin in Pediatrics. J Clin Pharmacol 2019;59:1584-96. [PMID: 31286535 DOI: 10.1002/jcph.1479] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
27 Riccobene TA, Khariton T, Knebel W, Das S, Li J, Jandourek A, Carrothers TJ, Bradley JS. Population PK Modeling and Target Attainment Simulations to Support Dosing of Ceftaroline Fosamil in Pediatric Patients With Acute Bacterial Skin and Skin Structure Infections and Community-Acquired Bacterial Pneumonia: Jo urnal of Clinical Pharmacology. The Journal of Clinical Pharmacology 2017;57:345-55. [DOI: 10.1002/jcph.809] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
28 Van den Anker JN, McCune S, Annaert P, Baer GR, Mulugeta Y, Abdelrahman R, Wu K, Krudys KM, Fisher J, Slikker W, Chen C, Burckart GJ, Allegaert K. Approaches to Dose Finding in Neonates, Illustrating the Variability between Neonatal Drug Development Programs. Pharmaceutics 2020;12:E685. [PMID: 32698409 DOI: 10.3390/pharmaceutics12070685] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
29 Padari H, Metsvaht T, Germovsek E, Barker CI, Kipper K, Herodes K, Standing JF, Oselin K, Tasa T, Soeorg H, Lutsar I. Pharmacokinetics of Penicillin G in Preterm and Term Neonates. Antimicrob Agents Chemother 2018;62:e02238-17. [PMID: 29463540 DOI: 10.1128/AAC.02238-17] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
30 Chua HC, Tse A, Smith NM, Mergenhagen KA, Cha R, Tsuji BT. Combatting the Rising Tide of Antimicrobial Resistance: Pharmacokinetic/Pharmacodynamic Dosing Strategies for Maximal Precision. Int J Antimicrob Agents 2021;57:106269. [PMID: 33358761 DOI: 10.1016/j.ijantimicag.2020.106269] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 An G. The Utility of Pharmacometric Models in Clinical Pharmacology Research in Infants. Curr Pharmacol Rep 2020;6:260-6. [PMID: 33767946 DOI: 10.1007/s40495-020-00234-5] [Reference Citation Analysis]
32 Terrier J, Daali Y, Fontana P, Csajka C, Reny JL. Towards Personalized Antithrombotic Treatments: Focus on P2Y12 Inhibitors and Direct Oral Anticoagulants. Clin Pharmacokinet 2019;58:1517-32. [PMID: 31250210 DOI: 10.1007/s40262-019-00792-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
33 Leopoldino RD, Santos MT, Costa TX, Martins RR, Oliveira AG. Risk assessment of patient factors and medications for drug-related problems from a prospective longitudinal study of newborns admitted to a neonatal intensive care unit in Brazil. BMJ Open 2019;9:e024377. [PMID: 31296505 DOI: 10.1136/bmjopen-2018-024377] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Tang BH, Guan Z, Allegaert K, Wu YE, Manolis E, Leroux S, Yao BF, Shi HY, Li X, Huang X, Wang WQ, Shen AD, Wang XL, Wang TY, Kou C, Xu HY, Zhou Y, Zheng Y, Hao GX, Xu BP, Thomson AH, Capparelli EV, Biran V, Simon N, Meibohm B, Lo YL, Marques R, Peris JE, Lutsar I, Saito J, Burggraaf J, Jacqz-Aigrain E, van den Anker J, Zhao W. Drug Clearance in Neonates: A Combination of Population Pharmacokinetic Modelling and Machine Learning Approaches to Improve Individual Prediction. Clin Pharmacokinet 2021. [PMID: 34041714 DOI: 10.1007/s40262-021-01033-x] [Reference Citation Analysis]
35 Gijsen M, Vlasselaers D, Spriet I, Allegaert K. Pharmacokinetics of Antibiotics in Pediatric Intensive Care: Fostering Variability to Attain Precision Medicine. Antibiotics (Basel) 2021;10:1182. [PMID: 34680763 DOI: 10.3390/antibiotics10101182] [Reference Citation Analysis]
36 Wu YE, Wang T, Yang HL, Tang BH, Kong L, Li X, Gao Q, Li X, Yao BF, Shi HY, Huang X, Wang WQ, Jacqz-Aigrain E, Allegaert K, van den Anker J, Tian XY, Zhao W. Population pharmacokinetics and dosing optimization of azlocillin in neonates with early-onset sepsis: a real-world study. J Antimicrob Chemother 2021;76:699-709. [PMID: 33188385 DOI: 10.1093/jac/dkaa468] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
37 Nascimento ARFD, Leopoldino RWD, Santos METD, Costa TXD, Martins RR. DRUG-RELATED PROBLEMS IN CARDIAC NEONATES UNDER INTENSIVE CARE. Rev Paul Pediatr 2020;38:e2018134. [PMID: 31939506 DOI: 10.1590/1984-0462/2020/38/2018134] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
38 Dao K, Guidi M, André P, Giannoni E, Basterrechea S, Zhao W, Fuchs A, Pfister M, Buclin T, Csajka C. Optimisation of vancomycin exposure in neonates based on the best level of evidence. Pharmacological Research 2020;154:104278. [DOI: 10.1016/j.phrs.2019.104278] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
39 van den Anker J, Allegaert K. Rational Use of Antibiotics in Neonates: Still in Search of Tailored Tools. Healthcare (Basel) 2019;7:E28. [PMID: 30781454 DOI: 10.3390/healthcare7010028] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
40 Allegaert K. Better medicines for neonates: Improving medicine development, testing, and prescribing. Early Hum Dev 2017;114:22-5. [PMID: 28899617 DOI: 10.1016/j.earlhumdev.2017.09.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
41 van Donge T, Bielicki JA, van den Anker J, Pfister M. Key Components for Antibiotic Dose Optimization of Sepsis in Neonates and Infants. Front Pediatr 2018;6:325. [PMID: 30420947 DOI: 10.3389/fped.2018.00325] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
42 Tu Q, Cotta M, Raman S, Graham N, Schlapbach L, Roberts JA. Individualized precision dosing approaches to optimize antimicrobial therapy in pediatric populations. Expert Rev Clin Pharmacol 2021;:1-17. [PMID: 34313180 DOI: 10.1080/17512433.2021.1961578] [Reference Citation Analysis]
43 Coppini R, Simons SHP, Mugelli A, Allegaert K. Clinical research in neonates and infants: Challenges and perspectives. Pharmacol Res 2016;108:80-7. [PMID: 27142783 DOI: 10.1016/j.phrs.2016.04.025] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
44 Fuchs A, Bielicki J, Mathur S, Sharland M, Van Den Anker JN. Reviewing the WHO guidelines for antibiotic use for sepsis in neonates and children. Paediatr Int Child Health 2018;38:S3-S15. [PMID: 29790842 DOI: 10.1080/20469047.2017.1408738] [Cited by in Crossref: 42] [Cited by in F6Publishing: 37] [Article Influence: 10.5] [Reference Citation Analysis]
45 Muhari-Stark E, Burckart GJ. Glomerular Filtration Rate Estimation Formulas for Pediatric and Neonatal Use. J Pediatr Pharmacol Ther 2018;23:424-31. [PMID: 30697127 DOI: 10.5863/1551-6776-23.6.424] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
46 Koch G, Datta AN, Jost K, Schulzke SM, van den Anker J, Pfister M. Caffeine Citrate Dosing Adjustments to Assure Stable Caffeine Concentrations in Preterm Neonates. The Journal of Pediatrics 2017;191:50-56.e1. [DOI: 10.1016/j.jpeds.2017.08.064] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
47 Keij FM, Achten NB, Tramper-Stranders GA, Allegaert K, van Rossum AMC, Reiss IKM, Kornelisse RF. Stratified Management for Bacterial Infections in Late Preterm and Term Neonates: Current Strategies and Future Opportunities Toward Precision Medicine. Front Pediatr 2021;9:590969. [PMID: 33869108 DOI: 10.3389/fped.2021.590969] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]